[Experimentation of targeted cardio-neurovascular risk screening in pharmacies].
| Autor: | Aly P, Tempremant G, Houppermans S, Maes-Patinier F, Vanbockstael V, Lemdani M |
|---|---|
| Jazyk: | francouzština |
| Zdroj: | Sante publique (Vandoeuvre-les-Nancy, France) [Sante Publique] 2018 November December; Vol. 30 (6), pp. 777-783. |
| DOI: | 10.3917/spub.187.0777 |
| Abstrakt: | Objectives: Pharmacists' involvement in the screening of cardio-neurovascular diseases could enhance the prevention of cardio-neurovascular risk factors. This research-action assesses the pertinence of targeted screening for cardio-neurovascular risk in pharmacies. Methods: This study was carried out within Lens-Hénin over the course of four months. The model included: the tracking of patients, excluding those with known cardio-neurovascular disease, with risk factors according to their age, sex, weight, family history of cardio-neurovascular diseases, smoking status; Screening for cardio-neurovascular risk with blood pressure measuring, blood total cholesterol, HDL cholesterol and the glycaemia by capillary blood sampling as well as the abdominal perimeter and the BMI. Patients were oriented according to results of screening. Results: 471 patients were screened, 218 (46%) had at least two risks, 236 (50%) had a cholesterol value greater than or equal 2 g/L, 176 (37.4%) had a blood pressure greater than or equal to limit value l, 104 (22%) patients had a BMI value greater than or equal to 30 kg/m2, 217 (46%) had an abdominal perimeter value greater than or equal to limit value and 17 (5.3%) patients had impaired fasting blood glucose. 373 (79%) patients were moved toward their general practitioner and at least 68 (18%) consulted. Conclusion: This research-action of targeted screening for cardiovascular risk in pharmacies proves to be relevant. The reproduction of a similar study in other territories is under consideration. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|